Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2000
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
10/05/2000WO2000058463A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058311A1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058304A1 Heterocyclic sulfonamide derivatives
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058285A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
10/05/2000WO2000058280A1 Carbocyclic sulfonamide derivatives
10/05/2000WO2000058279A1 Diaryl derivatives and their use as medicaments
10/05/2000WO2000058278A1 β-AMINO ACID DERIVATIVES
10/05/2000WO2000057922A1 Intramyocardial injection of autologous bone marrow
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057915A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
10/05/2000WO2000057883A1 Use of vasopeptidase inhibitors to treat angina pectoris
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000WO2000057863A2 Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
10/05/2000WO2000057862A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/05/2000WO2000057727A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions
10/05/2000WO2000057701A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000031133A3 Potassium channel interactors and uses therefor
10/05/2000WO2000030588A3 Treatment of hypertension
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000025804A3 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
10/05/2000WO2000013701A9 Angiogenically effective unit dose of fgf-2 and method of use
10/05/2000WO2000001716A3 Vasculoprotector
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000WO1998041232A3 Compositions for modulating responsiveness to corticosteroids
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368616A1 Use of vasopeptidase inhibitors to treat angina pectoris
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368455A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368234A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2361366A1 Novel compounds
10/05/2000CA2361016A1 Diaryl derivatives and their use as medicaments
10/05/2000CA2359652A1 Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension
10/05/2000CA2291286A1 Chitosan-containing soft capsule and process for producing the same
10/04/2000EP1041142A2 Universal donor cells
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040109A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000EP1039919A1 Composition for improving mental capabilities in mammals
10/04/2000EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
10/04/2000EP1039915A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039884A1 A method for the prevention and treatment of stunned myocardium
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000EP0690719B1 Dry mix formulation for bisphosphonic acids
10/04/2000CN1268891A Dietary supplements contg. natural ingredients
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057085C Heterocyclically substituted phenyl-cyclohexane carboxylcic acid derivatives
10/04/2000CN1057083C Tricyclic 1-aminoethylpyrrol derivative
10/04/2000CN1057008C Application of theaflavine for preparing medicine for treating viral myocarditis
10/04/2000CN1057006C Application of theaflavine for preparing medicine for treating thromboangiitis obliterans
10/04/2000CN1056982C Radiation theropeutic method for blood and assistant medicine therefor, and process for producing same
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
1 ... 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 ... 1595